Preliminary report: pharmacologic 11β-hydroxysteroid dehydrogenase type 1 inhibition increases hepatic fat oxidation in vivo and expression of related genes in rats fed an obesogenic diet

Metabolism: Clinical and Experimental

Volumn 59, Issue 1, 2010, Pages 114-117

  Berthiaume, Magalie ^a   Laplante, Mathieu ^a   Festuccia, William T ^a   Berger, Joel P ^b   Thieringer, Rolf ^b   Deshaies, Yves ^a  

^a LAVAL UNIVERSITY   (Canada)

^b MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE 1; [5 [4 [5 (2 TRIFLUOROMETHYLPHENYL) 4 METHYL 4H 1,2,4 TRIAZOL 3 YL]BICYCLO[2.2.2]OCT 1 YL] 3 (4 FLUOROPHENYL) 1,2,4 OXADIAZOLE; ENZYME INHIBITOR; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME INHIBITION; FATTY ACID OXIDATION; FATTY LIVER; FOOD INTAKE; GENE EXPRESSION; LIPID DIET; LIVER LEVEL; MALE; MITOCHONDRION; NONHUMAN; PEROXISOME; PRIORITY JOURNAL; RAT;

11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1; ANIMALS; GENE EXPRESSION REGULATION; LIPID METABOLISM; LIVER; MALE; OXIDATION-REDUCTION; RATS; RATS, SPRAGUE-DAWLEY;

EID: 72049107460     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2009.07.015     Document Type: Article

References (18)

1. Morton N.M., and Seckl J.R. 11β-Hydroxysteroid dehydrogenase type 1 and obesity. Front Horm Res 36 (2008) 146-164
2. Jamieson P.M., Chapman K.E., Edwards C.R., et al. 11β-Hydroxysteroid dehydrogenase is an exclusive 11β-reductase in primary cultures of rat hepatocytes: effect of physicochemical and hormonal manipulations. Endocrinology 136 (1995) 4754-4761
3. Paterson J.M., Morton N.M., Fievet C., et al. Metabolic syndrome without obesity: hepatic overexpression of 11β-hydroxysteroid dehydrogenase type 1 in transgenic mice. Proc Natl Acad Sci U S A 101 (2004) 7088-7093
4. Morton N.M., Holmes M.C., Fievet C., et al. Improved lipid and lipoprotein profile, hepatic insulin sensitivity, and glucose tolerance in 11β-hydroxysteroid dehydrogenase type 1 null mice. J Biol Chem 276 (2001) 41293-41300
5. Berthiaume M., Laplante M., Festuccia W.T., et al. 11β-Hydroxysteroid dehydrogenase type 1 inhibition improves triglyceridemia through reduced liver secretion and partitions lipids towards oxidative tissues. Am J Physiol Endocrinol Metab 293 (2007) E1045-E1052
6. Gu X., Dragovic J., Koo G.C., et al. Discovery of 4-heteroarylbicyclo[2.2.2]octyltriazoles as potent and selective inhibitors of 11β-HSD1: novel therapeutic agents for the treatment of metabolic syndrome. Bioorg Med Chem Lett 15 (2005) 5266-5269
7. Hultin M., Carneheim C., Rosenqvist K., et al. Intravenous lipid emulsions: removal mechanisms as compared to chylomicrons. J Lipid Res 36 (1995) 2174-2184
8. Berthiaume M., Laplante M., Festuccia W.T., et al. Additive action of 11β-HSD1 inhibition and PPAR-gamma agonism on hepatic steatosis and triglyceridemia in diet-induced obese rats. Int J Obes (Lond) 33 (2009) 601-604
9. Morton N.M., Paterson J.M., Masuzaki H., et al. Novel adipose tissue-mediated resistance to diet-induced visceral obesity in 11β-hydroxysteroid dehydrogenase type 1-deficient mice. Diabetes 53 (2004) 931-938
10. Hermanowski-Vosatka A., Balkovec J.M., Cheng K., et al. 11β-HSD1 inhibition ameliorates metabolic syndrome and prevents progression of atherosclerosis in mice. J Exp Med 202 (2005) 517-527
11. Wang S.J., Birtles S., de Schoolmeester J., et al. Inhibition of 11β-hydroxysteroid dehydrogenase type 1 reduces food intake and weight gain but maintains energy expenditure in diet-induced obese mice. Diabetologia 49 (2006) 1333-1337
12. Letteron P., Brahimi-Bourouina N., Robin M.A., et al. Glucocorticoids inhibit mitochondrial matrix acyl-CoA dehydrogenases and fatty acid β-oxidation. Am J Physiol 272 (1997) G1141-G1150
13. Gulick T., Cresci S., Caira T., et al. The peroxisome proliferator-activated receptor regulates mitochondrial fatty acid oxidative enzyme gene expression. Proc Natl Acad Sci U S A 91 (1994) 11012-11016
14. Patsouris D., Reddy J.K., Muller M., et al. Peroxisome proliferator-activated receptor α mediates the effects of high-fat diet on hepatic gene expression. Endocrinology 147 (2006) 1508-1516
15. Hermanowski-Vosatka A., Gerhold D., Mundt S.S., et al. PPARα agonists reduce 11β-hydroxysteroid dehydrogenase type 1 in the liver. Biochem Biophys Res Commun 279 (2000) 330-336
16. Lemberger T., Saladin R., Vazquez M., et al. Expression of the peroxisome proliferator-activated receptor α gene is stimulated by stress and follows a diurnal rhythm. J Biol Chem 271 (1996) 1764-1769
17. Yamauchi T., Kamon J., Minokoshi Y., et al. Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat Med 8 (2002) 1288-1295
18. Yamauchi T., Nio Y., Maki T., et al. Targeted disruption of AdipoR1 and AdipoR2 causes abrogation of adiponectin binding and metabolic actions. Nat Med 13 (2007) 332-339